These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients. Sciuto R; Festa A; Pasqualoni R; Semprebene A; Rea S; Bergomi S; Maini CL Breast Cancer Res Treat; 2001 Mar; 66(2):101-9. PubMed ID: 11437096 [TBL] [Abstract][Full Text] [Related]
9. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases. Küçük NO; Ibiş E; Aras G; Baltaci S; Ozalp G; Bedük Y; Canakci N; Soylu A Ann Nucl Med; 2000 Aug; 14(4):239-45. PubMed ID: 11023023 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases. Liepe K; Kropp J; Runge R; Kotzerke J Br J Cancer; 2003 Aug; 89(4):625-9. PubMed ID: 12915868 [TBL] [Abstract][Full Text] [Related]
12. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy. Liepe K; Kropp J; Hliscs R; Franke WG Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588 [TBL] [Abstract][Full Text] [Related]
13. Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy. Zafeirakis A; Zissimopoulos A; Baziotis N; Limouris GS Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):91-102. PubMed ID: 21068716 [TBL] [Abstract][Full Text] [Related]
14. Rhenium-186-HEDP palliative treatment in disseminated bone metastases due to prostate cancer. Limouris G; Shukla SK; Manetou A; Kouvaris I; Plataniotis G; Triantafyllou N; Rigas AV; Vlahos L Anticancer Res; 1997; 17(3B):1699-704. PubMed ID: 9179222 [TBL] [Abstract][Full Text] [Related]
15. [Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP]. Klutmann S; Bohuslavizki KH MMW Fortschr Med; 1999 Nov; 141(44):38-9. PubMed ID: 10912142 [TBL] [Abstract][Full Text] [Related]
16. Strontium 89 therapy for the palliation of pain due to osseous metastases. Robinson RG; Preston DF; Schiefelbein M; Baxter KG JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352 [TBL] [Abstract][Full Text] [Related]
17. Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world study. Lange R; Overbeek F; de Klerk JM; Pasker-de Jong PC; van den Berk AM; Ter Heine R; Rodenburg CJ; Kooistra A; Hendrikse NH; Bloemendal HJ Nuklearmedizin; 2016 Sep; 55(5):188-95. PubMed ID: 27443809 [TBL] [Abstract][Full Text] [Related]
18. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain. Liepe K; Runge R; Kotzerke J J Cancer Res Clin Oncol; 2005 Jan; 131(1):60-6. PubMed ID: 15449184 [TBL] [Abstract][Full Text] [Related]
19. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. Maxon HR; Schroder LE; Hertzberg VS; Thomas SR; Englaro EE; Samaratunga R; Smith H; Moulton JS; Williams CC; Ehrhardt GJ J Nucl Med; 1991 Oct; 32(10):1877-81. PubMed ID: 1717669 [TBL] [Abstract][Full Text] [Related]
20. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. Dafermou A; Colamussi P; Giganti M; Cittanti C; Bestagno M; Piffanelli A Eur J Nucl Med; 2001 Jul; 28(7):788-98. PubMed ID: 11504074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]